Philips Q1 results beat estimates on strong China growth
[AMSTERDAM] Dutch health technology company Philips' first-quarter results beat expectations on Monday, as customers in China and the United States increased their demand for its high-end hospital equipment.
Core profit in the first three months of the year rose 15 per cent to 344 million euros (S$556.12 million), Philips said, on a comparable sales growth of 5 per cent and a 10 per cent increase in new orders.
"While there is more work to be done, 2018 started well," Chief Executive Frans van Houten said in a statement, reaffirming the company's target of a 4-6 per cent sales growth for the year.
Analysts in a Reuters poll predicted adjusted earnings before interest, taxes and amortisation (EBITA) for the first quarter of 332 million euros, on 4.3 per cent higher sales.
Since the separation of its lighting division in 2016, Philips focuses on medical devices and healthcare products ranging from medical scanners to toothbrushes.
Growth was strongest in the diagnosis and treatment division, as strong demand for ultrasound machines, medical scanners and other hospital equipment in China and the United States led to a 9 percent increase in sales.
The connected care and informatics business, which includes patient monitoring systems and software used by hospitals to gather and analyse data, was less thriving, as comparable sales were flat. Sales of consumer products rose 4 per cent.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Jim Beam owner bets on canned vodka cocktails to double revenue
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Cordlife served letter of demand, notice of claim from customers
IndoAgri appoints former EDB chairman Philip Yeo as chairman and lead independent director
GSK profit drops 23% in Q1 on higher costs